<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
/ / Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person
Patricof Alan J.
(Last) (First) (Middle)
c/o Patricof & Co. Ventures, Inc.
445 Park Avenue, 11th Floor
(Street)
New York New York 10022
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Creative BioMolecules, Inc. (CEMI)
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
February, 1997
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person to Issuer (Check all applicable)
/ / Director /X/ 10% Owner
/ / Officer (give title below) / / Other (specify below)
<TABLE>
<CAPTION>
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
5. Amount
of Secu-
rities
Bene-
ficially
4. Securities Acquired (A) Owned at 6. Ownership
2. Trans- 3. Trans- or Disposed of (D) End of Form:
action action (Instr. 3, 4 and 5) Issuer's Direct 7. Nature of
Date Code ----------------------------- Fiscal (D) or Indirect
(Month/ (Instr. 8) (A) Year Indirect Beneficial
1. Title of Security Day/ ------------- Amount or Price (Instr. (I) Ownership
(Instr. 3) Year) Code V (D) 3 and 4) (Instr. 4) (Instr. 4)
- ----------------------------- ---------- ------ ----- ------------ --- ---------- ----------- ------------- ---------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock, $.01 par value 2/4/97 S 10,000 D $10.50 I
Common Stock, $.01 par value 2/5/97 S 130,000 D $11.125 4,032,150 I (1)(2)
Common Stock, $.01 par value 45,878 D
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<TABLE>
<CAPTION>
Table II--Derivative Securities Acquired, Disposed of or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
2. Conver- 5. Number of Deriv- 6. Date Exercisable
sion or 3. Trans- ative Securities and Expiration Date
Exercise action 4. Transac- Acquired (A) or (Month/Day/Year)
Price of Date tion Code Disposed of (D) ----------------------
Deriv- (Month/ (Instr. 8) (Instr. 3, 4, and 5) Date
1. Title of Derivative Security ative Day/ ------------- -------------------------- Exercis- Expiration
(Instr. 3) Security Year) Code V (A) (D) able Date
- ---------------------------------------- ----------- ---------- ------ ----- ------------ ------------ ---------- ----------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
<CAPTION>
9. Number of 10. Ownership
Derivative Form of
Securities Derivative
7. Title and Amount of Underlying Benefi- Security:
Securities (Instr. 3 and 4) cially Direct 11. Nature of
---------------------------------------- 8. Price of Owned at (D) or Indirect
Amount or Derivative End of Indirect Beneficial
1. Title of Derivative Title Number of Security Month (I) Ownership
Security (Instr. 3) Shares (Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4)
- --------------------------- --------------------------- ----------- ------------- ------------- -------------- ---------------
<S> <C> <C> <C> <C> <C> <C>
</TABLE>
Explanation of Responses:
(1) These shares are held directly by the following:
149,926 shares by APA Excelsior Venture Capital Holdings (Jersey), Ltd.
("Excelsior Jersey"); 764,994 shares by APAX Ventures II, Ltd. ("Ventures II");
306,987 shares by APAX CR II (A) ("CRIIA"); 121,913 shares of APAX CR II (C)
("CRIIC"); 710,674 shares by APAX Ventures III ("Ventures III"); 870,741 shares
by APAX Ventures III International Partners, L.P. ("Ventures III
International"); 406,005 shares by APAX Ventures IV ("Ventures IV"); 700,910
shares by APAX Ventures IV International Partners, L.P. ("Ventures IV
International") and 45,878 shares by the Reporting Person. (2) The Reporting
Person is (i) the Chairman of the Board and Chief Executive Officer of Patricof
& Co. Ventures, Inc. ("Patricof"), the manager of Excelsior Jersey; (ii) a
director of APAX Partners & Co. Ventures Limited, the managing general partner
of Ventures III International and Ventures IV International and the general
partner of Ventures III and Ventures IV; (iii) a director of APAX Venture
Capital Managers (Jersey) Limited, the manager of Ventures II; and (iv) a
director of APAX Partners & Cie Gestion, the manager of CRIIA and CRIIC. The
Reporting Person disclaims beneficial ownership of the securities held by these
entities.
By: Date
/s/ Alan J. Patricof March 10, 1997
**Signature of Reporting Person
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
